SCHEMBL6666439

SCHEMBL6666439

CCOC(=O)CCCCc1ccc(C#Cc2ccc3c(c2)C(C)(C)CCO3)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 6/20 0.36
RARB P10826 6/20 0.36
RARG P13631 6/20 0.36
CYP3A4 P08684 2/20 0.36
KMT2A Q03164 2/20 0.36
RXRA P19793 2/20 0.35
HNF4A P41235 1/20 0.35
PRSS1 P07477 3/20 0.34
PRSS2 P07478 3/20 0.34
PRSS3 P35030 3/20 0.34
CYP26A1 O43174 2/20 0.34
CYP26B1 Q9NR63 1/20 0.34
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
CRABP2 P29373 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656363 0.90 PRSS1 (0.34) RARARARBRARGCYP3A4KMT2A
SCHEMBL6668825 0.89 PRSS1 (0.33) RARARARBRARGCYP3A4KMT2A
SCHEMBL9139472 0.88 RARA (0.39) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817759 0.88 CYP26A1 (0.40) RARARARBRARGCYP3A4KMT2A
SCHEMBL9271283 0.88 RARB (0.44) RARARARBRARGCYP3A4KMT2A
SCHEMBL6665834 0.87 RXRA (0.37) RARARARBRARGKMT2ARXRA
SCHEMBL6669164 0.86 RXRA (0.36) RARARARBRARGKMT2ARXRA
SCHEMBL8865169 0.86 KDM4E (0.33) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817779 0.86 RARA (0.37) RARARARBRARGCYP3A4KMT2A
SCHEMBL9817748 0.85 CYP26A1 (0.41) RARARARBRARGCYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5380877-A Psoriasis treatment; retinoic acid-like activity ALLERGAN, INC. (US) 1995-01-10 US claimed
EP-0785782-B1 USE OF DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY ALLERGAN INC (US) 2004-09-08 EP disclosed
EP-0785782-A1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY Allergan (US) 1997-07-30 EP disclosed
US-5602130-A ORNITHINE DECARBOXYLASE ENZYME INHIBITOR TREATING SKIN DISORDER, INHIBITING CELL HYPERPROLIFERATION ALLERGAN 1997-02-11 US disclosed
WO-1996011686-A1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY ALLERGAN (US) 1996-04-25 WO disclosed
US-5380877-A Psoriasis treatment; retinoic acid-like activity ALLERGAN, INC. (US) 1995-01-10 US disclosed
US-5354752-A A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis ALLERGAN, INC. (US) 1994-10-11 US disclosed
US-5348972-A In treatment of skin disorders such as acne and psoriasis ALLERGAN, INC. (US) 1994-09-20 US disclosed
US-5234926-A Skin disorders ALLERGAN, INC. (US) 1993-08-10 US disclosed
EP-0284288-B1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID LIKE ACTIVITY ALLERGAN, INC (US) 1992-05-27 EP disclosed
US-5089509-A Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC. (US) 1992-02-18 US disclosed
EP-0284288-A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC (US) 1988-09-28 EP disclosed